News

• April 10, 2007
  

  Pharmaceutical Companies and FDA Making Strides

  Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Food and Drug Administration approval to bring the drugs to market.
• March 10, 2007
  

  C-Path Adopts Rosetta Resolver® System for the PSTC

  Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-Path’s Predictive Safety Testing Consortium.
• March 10, 2007
  

  Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional Hearings

  President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterday at the Committee on Energy and Commerce’s Subcommittee Hearing on Oversight and Investigations entitled “The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply.”
• November 10, 2006
  

  Tucson Nonprofit Seeks to Get Cures to Patients Faster

  A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and development had been rising for the previous decade, applications for new drugs and medical products had been falling.
• November 10, 2006
  

  New Corporate Members and Leaders for C-Path’s Predictive Safety Testing Consortium Announced

  The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Consortium (PSTC)…